UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature

Journal of kidney cancer and VHL, 2022-05, Vol.9 (2), p.32-38

2022

Volltextzugriff (PDF)

End‐of‐life planning and its relevance for patients' and oncologists' decisions in choosing cancer therapy

Cancer, 2008-12, Vol.113 (S12), p.3540-3547

2008

Volltextzugriff (PDF)

Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life

Cancer, 2024-07

2024

Volltextzugriff (PDF)

Factors associated with clinical trial participation for patients with prostate cancer

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.96-96

2020

Volltextzugriff (PDF)

Angiosarcoma of Small Bowel Presenting with Obstruction : Novel Observations on a Rare Diagnostic Entity with Unique Clinical Presentation

Case reports in gastrointestinal medicine, 2012-01, Vol.2012 (2012), p.1-5

2012

Volltextzugriff (PDF)

Anterior Mediastinal Mass in a Young Marijuana Smoker: A Rare Case of Small-Cell Lung Cancer

Case Reports in Medicine, 2012-01, Vol.2012 (2012), p.1-4

2012

Volltextzugriff (PDF)

Breaking bad news: during the holiday season

BMJ supportive & palliative care, 2023-12, Vol.13 (4), p.442-444

2023

Volltextzugriff (PDF)

Factors associated with clinical trial participation for patients with renal cell carcinoma

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.670-670

2020

Volltextzugriff (PDF)

A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

Molecular cancer therapeutics, 2023-04, Vol.22 (4), p.511-518

2023

Volltextzugriff (PDF)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer

The Prostate, 2024-10, Vol.84 (14), p.1301-1308

2024

Volltextzugriff (PDF)

Psychological Determinants of Physician Variation in End-of-Life Treatment Intensity: A Systematic Review and Meta-Synthesis

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (6), p.1516-1525

2023

Volltextzugriff (PDF)

Feasibility and Acceptability of an Online Oncologist Training to Optimize Oncologist-Patient Communication and Value-Concordant Care in Advanced Cancer

Journal of palliative medicine, 2023-10, Vol.26 (10), p.1386-1390

2023

Volltextzugriff (PDF)

Evaluating feasibility and acceptability of an innovative personalized hybrid longitudinal communication skills training program

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.428-428

2023

Volltextzugriff (PDF)

An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of The Treatment of Renal Cancer Carcinoma

Kidney cancer journal, 2023-10, Vol.21 (3), p.96-100

2023

Volltextzugriff (PDF)

Oncologists and end-of-life care

Journal of palliative medicine, 2009-02, Vol.12 (2), p.116-116

Saraiya, Biren

2009

Volltextzugriff (PDF)

Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer

Cancer, 2020-07, Vol.126 (13), p.2991-3001

2020

Volltextzugriff (PDF)

Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer

Pharmacotherapy, 2009-11, Vol.29 (11), p.1344-1356

2009

Volltextzugriff (PDF)

A phase Ib study of troriluzole (BHV-4157) in combination with nivolumab

Journal of clinical oncology, 2020-02, Vol.38 (5_suppl), p.79-79

2020

Volltextzugriff (PDF)

Abstract A075: Racial and ethnic inequities in receipt of degarelix among patients diagnosed with advanced prostate cancer in United States

Cancer epidemiology, biomarkers & prevention, 2024-09, Vol.33 (9_Supplement), p.A075-A075

2024

Volltextzugriff (PDF)

Integration of Palliative and Supportive Care Into the Management of Genitourinary Malignancies

American Society of Clinical Oncology educational book, 2022-04, Vol.42 (42), p.1-350

2022

Volltextzugriff (PDF)

Top Ten Tips Palliative Care Clinicians Should Know About Urological Care

Journal of palliative medicine, 2023-02, Vol.26 (2), p.264-269

2023

Volltextzugriff (PDF)

Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) with progressive disease following immune checkpoint inhibitor (ICI) therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5037-5037

2020

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(45)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature

End‐of‐life planning and its relevance for patients' and oncologists' decisions in choosing cancer therapy

Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life

Factors associated with clinical trial participation for patients with prostate cancer

Angiosarcoma of Small Bowel Presenting with Obstruction : Novel Observations on a Rare Diagnostic Entity with Unique Clinical Presentation

Anterior Mediastinal Mass in a Young Marijuana Smoker: A Rare Case of Small-Cell Lung Cancer

Breaking bad news: during the holiday season

Factors associated with clinical trial participation for patients with renal cell carcinoma

A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer

Psychological Determinants of Physician Variation in End-of-Life Treatment Intensity: A Systematic Review and Meta-Synthesis

Feasibility and Acceptability of an Online Oncologist Training to Optimize Oncologist-Patient Communication and Value-Concordant Care in Advanced Cancer

Evaluating feasibility and acceptability of an innovative personalized hybrid longitudinal communication skills training program

An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of The Treatment of Renal Cancer Carcinoma

Oncologists and end-of-life care

Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer

A phase Ib study of troriluzole (BHV-4157) in combination with nivolumab

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness

Abstract A075: Racial and ethnic inequities in receipt of degarelix among patients diagnosed with advanced prostate cancer in United States

Integration of Palliative and Supportive Care Into the Management of Genitourinary Malignancies

Top Ten Tips Palliative Care Clinicians Should Know About Urological Care

Cabozantinib Plus Nivolumab Phase I Expansion Study in Metastatic Urothelial Carcinoma Patients Refractory to Immune Checkpoint Inhibitor Therapy

Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) with progressive disease following immune checkpoint inhibitor (ICI) therapy

Aktive Filter

Suchergebnisse filtern